Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.

Emerging infectious diseases - 1 Apr 2011

Renaud Christian, Boudreault Alexandre A, Kuypers Jane, Lofy Kathryn H, Corey Lawrence, Boeckh Michael J, Englund Janet A

Abstract excerpt

Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275Y mutation in immunocompromised patients, we retrospectively identified 49 hematology-oncology patients infected with pandemic (H1N1) 2009 virus. Samples from 33 of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Child
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunocompromised Host

Share to Influenza A Virus, H1N1 Subtype

Share to Influenza, Human

Share to Respiratory Tract Infections

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 21470455
DOI: 10.3201/eid1704.101429
PMCID: PMC3290123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.PMID 21470455Read ↗

Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.Semantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.Semantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of KoreaSemantic proximity Read ↗

Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus.Semantic proximity Read ↗

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.Semantic proximity Read ↗

Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.Semantic proximity Read ↗

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infectionsSemantic proximity Read ↗

Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.Semantic proximity Read ↗

Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised HostsSemantic proximity Read ↗

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patientSemantic proximity Read ↗

Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).Semantic proximity Read ↗

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.